Basics Abeona Therapeutics Inc. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. IPO Date: November 9, 1984 Sector: Healthcare Industry: Biotech Market Cap: $281.25M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 3.55% Avg Daily Range (30 D): $0.11 | 2.21% Avg Daily Range (90 D): $0.13 | 2.43% Institutional Daily Volume Avg Daily Volume: .77M Avg Daily Volume (30 D): 1.08M Avg Daily Volume (90 D): 1.42M Trade Size Avg Trade Size (Sh.): 210 Avg Trade Size (Sh.) (30 D): 122 Avg Trade Size (Sh.) (90 D): 136 Institutional Trades Total Inst.Trades: 405 Avg Inst. Trade: $1.46M Avg Inst. Trade (30 D): $.9M Avg Inst. Trade (90 D): $2.14M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.75M Avg Closing Trade (30 D): $1.1M Avg Closing Trade (90 D): $.8M Avg Closing Volume: 47.47K     News Dec 31, 2025 @ 12:30 PM Abeona Therapeutics® Announces New Employee Ind... Source: Na Nov 12, 2025 @ 4:37 PM Here's Why Abeona Therapeutics Popped Higher Today... Source: Lee Samaha Sep 2, 2025 @ 8:59 AM Trends & Growth Strategies in the $13.5 Billion Ca... Source: Researchandmarkets.Com Aug 12, 2025 @ 2:00 PM AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 ... Source: Dea Belazi May 14, 2025 @ 5:57 PM US FDA Orphan Drug Rare Disease Market Clinical Tr... Source: Kuick Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.1 $2.07 $-.24 Diluted EPS $-.1 $1.71 $-.24 Revenue $ M $ .4M $ M Gross Profit $ $ $ Net Income / Loss $ -5.16M $ 108.83M $ -12.03M Operating Income / Loss $ -24.02M $ -22.79M $ -19.73M Cost of Revenue $ $ $ Net Cash Flow $ -80.65M $ 147.6M $ -7.42M PE Ratio     Splits Jul 05, 2022:   1:25 Oct 24, 2014:   1:50 Jun 05, 2006:   1:5